- Pharmaceutical companies
- Viatris
Viatris
Phone: +17245141800
Type | Public |
---|---|
Traded as |
|
ISIN | US92556V1061 |
Industry |
|
Predecessors |
|
Founded | November 16, 2020 (2020-11-16) |
Headquarters | Canonsburg, Pennsylvania, U.S. |
Area served | Worldwide |
Key people |
|
Products |
|
Revenue | US$17.89 billion (2021) |
Net income | US$−1.27 billion (2021) |
Total assets | US$54.84 billion (2021) |
Total equity | US$20.49 billion (2021) |
Number of employees | c. 37,000 (December 2021) |
Website | viatris.com |
At Viatris, we have one of the strongest global commercial infrastructures in the industry, with a balanced reach across North America, Europe, the Asia Pacific region and emerging markets. Our high quality global manufacturing, scientific excellence and vast supply chain network mean we are uniquely positioned to improve access to medicine for patients worldwide.
For detailed contact information visit location pages below.
Viatris's locations around the world
Europe
North America
South America
Oceania
Clinical Trials sponsored by Viatris
-
Viatris KoreaReclutamientoDolor neuropático periféricoCorea, república de
-
Viatris Specialty LLCTerminado
-
Viatris Specialty LLCTerminadoPotencial de abusoEstados Unidos
-
Viatris Specialty LLCTerminadoPotencial de abusoEstados Unidos
-
Viatris Inc.ReclutamientoAnticoncepciónAlemania
-
Viatris Pharmaceuticals Japan IncTerminadoHipertensión arterial pulmonarJapón
-
Viatris Inc.Aún no reclutandoEstudio de BioequivalenciaTailandia
-
Viatris Inc.Aún no reclutandoInsuficiencia cardíaca crónica
-
MEDA PHARMA SPA, a Viatris companyAún no reclutandoDermatitis atópica leve a moderada
-
COPD FoundationViatris Inc.Reclutamiento